Department of Clinical, Neuro and Developmental Psychology,EMGO Institute for Health and Care Research,Vrije Universiteit Amsterdam,Van der Boechorststraat 1, 1081 BT Amsterdam,The Netherlands.
Psychol Med. 2018 Oct;48(13):2140-2152. doi: 10.1017/S0033291717003622. Epub 2018 Jan 24.
More than half of patients who present with depressive disorders also have elevated comorbid anxiety symptoms. Given the high comorbidity between these disorders, it is important to understand the extent that psychotherapies for depression additionally ameliorate symptoms of anxiety.
Systematic searches were conducted in PubMed, PSYCinfo, EMBASE, and the Cochrane Registry of Controlled Trials. Included studies were randomized controlled trials that compared psychotherapy compared with a control condition for the treatment of adults with a primary diagnosis or elevated symptoms of depression and that examined the effects of treatment on anxiety outcomes. Acute phase depression and anxiety (continuous measure) outcomes were extracted. Effect sizes were calculated by subtracting the average post-treatment scores of the psychotherapy group from the average post-treatment scores of the comparison group divided by the pooled standard deviation.
Fifty-two studies of varying quality met the inclusion criteria. Pooled effect sizes showed that anxiety outcomes were significantly lower in the psychotherapy conditions than in control conditions at post-treatment [g = 0.52; 95% confidence interval (CI) 0.44-0.60; NNT (numbers-needed-to-treat) = 3.50]. Moderate heterogeneity was observed (I2 = 55%, 95% CI 40-66). Bivariate metaregression analysis revealed a significant association between depression and anxiety effect sizes at post-treatment Longer-term follow-ups of up to 14 months post-baseline showed indications for a small lasting effect of psychotherapy on anxiety outcomes (g = 0.27).
This meta-analysis provides evidence that psychotherapy aimed at depression can also reduce anxiety symptoms in relation to control conditions.
超过一半的出现抑郁障碍的患者还伴有升高的共病焦虑症状。鉴于这些疾病的高共病性,了解治疗抑郁症的心理疗法在多大程度上可以改善焦虑症状非常重要。
在 PubMed、PSYCinfo、EMBASE 和 Cochrane 对照试验登记处进行了系统搜索。纳入的研究是比较心理疗法与对照条件治疗主要诊断为抑郁或焦虑症状升高的成年人的随机对照试验,并且检查了治疗对焦虑结果的影响。提取急性抑郁和焦虑(连续测量)结局。通过从心理治疗组的平均治疗后评分中减去比较组的平均治疗后评分,再除以合并标准偏差来计算效应量。
有 52 项研究质量不同,符合纳入标准。荟萃分析显示,治疗后心理治疗组的焦虑结局明显低于对照组[g=0.52;95%置信区间(CI)0.44-0.60;NNT(需要治疗的人数)=3.50]。观察到中等程度的异质性(I2=55%,95%CI 40-66)。双变量荟萃回归分析显示,治疗后抑郁和焦虑效应大小之间存在显著关联。最长达 14 个月的基线后随访表明,心理疗法对焦虑结局有持续小的效果(g=0.27)。
这项荟萃分析提供了证据表明,针对抑郁症的心理疗法也可以降低与对照组相关的焦虑症状。